Nippon India Pharma Fund Direct G
Summary Info
Fund Name
: Nippon India Mutual Fund
Scheme Name
: Nippon India Pharma Fund Direct G
AMC
: Nippon India Mutual Fund
Type
: Open
Category
: Equity - Pharma
Launch Date
: 01-Jan-2013
Fund Manager
: Sailesh Raj Bhan
Net Assets (Rs. cr)
: 8357.03
Nippon India Pharma Fund Direct G - Nav Details
Nav Date
: 16-Sep-2025
NAV [Rs.]
: 577.961
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
:
Exit Load %
:
Nippon India Pharma Fund Direct G- NAV Chart
Nippon India Pharma Fund Direct G- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | 0.99 | -0.41 | 0.83 | 11.92 | -1.2 | 24.28 | 19.49 | 18.06 |
| Category Avg | 1.04 | 0.28 | 2.61 | 13.13 | -0.28 | 24.53 | 19.02 | 16.55 |
| Category Best | 2.41 | 3.5 | 5.12 | 16.95 | 9.57 | 29.72 | 22.03 | 34.35 |
| Category Worst | 0.31 | -1.12 | -0.24 | 9.23 | -11.76 | 20.64 | 14.41 | -2.25 |
Nippon India Pharma Fund Direct G- Latest Dividends
No Records Found
Nippon India Pharma Fund Direct G- Investment Details
Min. Investment(Rs.)
: 5000
Increm.Investment(Rs.)
: 1000
In & Out
In
InName Of The CompanyNo Of Shares
--
Out
InName Of The CompanyNo Of Shares
--
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 11.94 | 6256349 | 997.57 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 7.34 | 1000031 | 613.16 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 6.09 | 3200000 | 508.60 |
| Equity | Lupin | Pharmaceuticals & Biotechnology | 6.09 | 2683991 | 508.58 |
| Equity | Apollo Hospitals | Healthcare Services | 5.91 | 648795 | 493.73 |
| Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 5.90 | 3916074 | 493.46 |
| Equity | Medplus Health | Retailing | 3.65 | 3627277 | 305.39 |
| Equity | Vijaya Diagnost. | Healthcare Services | 3.48 | 2886684 | 290.92 |
| Equity | Glaxosmi. Pharma | Pharmaceuticals & Biotechnology | 3.04 | 913226 | 254.33 |
| Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 2.96 | 1320549 | 247.14 |
| Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 2.84 | 959323 | 237.68 |
| Equity | Thyrocare Tech. | Healthcare Services | 2.63 | 1733833 | 219.38 |
| Equity | Abbott India | Pharmaceuticals & Biotechnology | 2.59 | 68677 | 216.19 |
| Equity | Sai Life | Pharmaceuticals & Biotechnology | 2.52 | 2555745 | 210.77 |
| Equity | Dr Lal Pathlabs | Healthcare Services | 2.41 | 609112 | 201.54 |
| Equity | Zydus Lifesci. | Pharmaceuticals & Biotechnology | 2.35 | 2000632 | 196.27 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 2.24 | 757496 | 187.20 |
| Equity | Narayana Hrudaya | Healthcare Services | 2.16 | 1029215 | 180.50 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 2.09 | 1702630 | 175.01 |
| Equity | J B Chemicals & | Pharmaceuticals & Biotechnology | 2.06 | 999649 | 172.36 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 2.05 | 323678 | 171.66 |
| Equity | Pfizer | Pharmaceuticals & Biotechnology | 1.96 | 318249 | 164.08 |
| Equity | Biocon | Pharmaceuticals & Biotechnology | 1.76 | 4226436 | 147.22 |
| Equity | Sanofi India | Pharmaceuticals & Biotechnology | 1.42 | 230272 | 118.45 |
| Equity | Suraksha Diagno. | Healthcare Services | 1.39 | 3896349 | 116.22 |
| Equity | Sanofi Consumer | Pharmaceuticals & Biotechnology | 1.33 | 213659 | 110.79 |
| Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 1.30 | 785412 | 108.73 |
| Equity | Torrent Pharma. | Pharmaceuticals & Biotechnology | 1.29 | 303364 | 107.99 |
| Equity | Fortis Health. | Healthcare Services | 1.20 | 1103889 | 100.61 |
| Equity | Anthem Bioscienc | Pharmaceuticals & Biotechnology | 1.04 | 1058503 | 86.59 |
| Equity | Syngene Intl. | Healthcare Services | 0.96 | 1280492 | 80.14 |
| Equity | Akums Drugs | Pharmaceuticals & Biotechnology | 0.82 | 1515264 | 68.83 |
| Equity | Emcure Pharma | Pharmaceuticals & Biotechnology | 0.78 | 470272 | 65.52 |
| Equity | Astrazeneca Phar | Pharmaceuticals & Biotechnology | 0.63 | 62568 | 52.93 |
| Equity | Indoco Remedies | Pharmaceuticals & Biotechnology | 0.59 | 1834924 | 48.91 |
| Equity | Orchid Pharma | Pharmaceuticals & Biotechnology | 0.43 | 492727 | 36.16 |
| Equity | Concord Biotech | Pharmaceuticals & Biotechnology | 0.22 | 111738 | 18.79 |
| Cash & Cash Equivalent | |||||
| Reverse Repo | TREPS | -/- | 0.41 | 0 | 34.43 |
| Net CA & Others | Net CA & Others | -/- | 0.13 | 0 | 8.97 |
| Cash & Cash Equivalent | C C I | -/- | 0.00 | 0 | 0.04 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
Nippon India Mutual Fund
Incorporation Date:
24-Feb-1995
Total Assets Managed (Cr.):
6,17,875.24
Trustee/s:
Mr. A N Shanbhag - Associ, Nippon Life India Trustee
Chairman:
NA
CEO / MD:
Mr. Sundeep Sikka
CIO:
NA
President:
NA
Director/s:
Mr. Akira Shibata, Mr. Sushil C. Tripathi, Mr. Kazuhide Toda, Mr. Takayuki Murai
Compliance Officer/s:
Mr. Muneesh Sud
Investor Service Officer/s:
Mr. Milind Nesarikar
Fund Manager/s:
Sailesh Raj Bhan
Auditors:
Haribhakti & Co LLP Chart
OTHER INFORMATION
Registered Office:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact Nos:
022-68087000/1860260111
Fax:
022-68087097
Website:
